Elmar Kraus's Stock Ratings

DZ Bank Analyst

Elmar Kraus is an analyst at DZ Bank. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 05/12/2025

Overall Average Return

25.8%

Smart Score

68.8%

Overall Average Return Percentile

85th

Number of Ratings

12
Buy NowGet Alert
02/21/2024LLYBuy Now
Eli Lilly
$758.518.11%
Elmar Kraus68%
→ $820DowngradeBuy → HoldGet Alert
02/11/2022GSKBuy Now
GSK
$37.50
Elmar Kraus68%
DowngradeBuy → HoldGet Alert
02/11/2022AZNBuy Now
AstraZeneca
$68.88
Elmar Kraus68%
UpgradeSell → HoldGet Alert
01/21/2022LLYBuy Now
Eli Lilly
$758.51-61.64%
Elmar Kraus68%
→ $291UpgradeHold → BuyGet Alert
08/05/2021LLYBuy Now
Eli Lilly
$758.51-62.03%
Elmar Kraus68%
→ $288UpgradeHold → BuyGet Alert
02/04/2021PFEBuy Now
Pfizer
$22.9478.73%
Elmar Kraus68%
→ $41UpgradeHold → BuyGet Alert
05/14/2020MDTBuy Now
Medtronic
$85.897.11%
Elmar Kraus68%
→ $92DowngradeBuy → HoldGet Alert
03/25/2020MDTBuy Now
Medtronic
$85.894.79%
Elmar Kraus68%
→ $90UpgradeHold → BuyGet Alert
03/18/2020GILDBuy Now
Gilead Sciences
$103.20
Elmar Kraus68%
UpgradeHold → BuyGet Alert
02/28/2020GILDBuy Now
Gilead Sciences
$103.20
Elmar Kraus68%
DowngradeBuy → HoldGet Alert
08/28/2019PFEBuy Now
Pfizer
$22.9456.93%
Elmar Kraus68%
→ $36UpgradeSell → HoldGet Alert
06/22/2018LLYBuy Now
Eli Lilly
$758.51
Elmar Kraus68%
DowngradeBuy → HoldGet Alert